OMERS Administration Corp
IMMX icon

OMERS Administration Corp’s Immix Biopharma IMMX Stock Holding History

OMERS Administration Corp’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20,400
Closed -$186K – 1022
2026
Q1 		$186K Sell
20,400
-54,300
-73% -$399K ﹤0.01% 931
2025
Q4 		$391K Buy
+74,700
New +$307K ﹤0.01% 749

Other funds holding IMMX

Jupiter Topco
Jupiter Topco New York $245B AUM
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
Eventide Asset Management
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Deep Track Capital
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

OMERS Administration Corp's IMMX Position: Q2 2026 in Review

OMERS Administration Corp sold out of Immix Biopharma (IMMX) in Q2 2026, closing a stake of 20,400 shares — an estimated $186K sold.

OMERS Administration Corp first reported a position in IMMX in Q4 2025 and held it in 2 quarters. The position peaked at $391K in Q4 2025. 109 funds tracked by Wall St. Rank hold IMMX as of Q2 2026.

  • OMERS Administration Corp reported no remaining Immix Biopharma position as of Q2 2026 after selling out during the quarter.
  • OMERS Administration Corp sold 20,400 Immix Biopharma shares in Q2 2026, an estimated $186K.
  • OMERS Administration Corp first reported a position in Immix Biopharma in Q4 2025 and held it in 2 quarters.
  • OMERS Administration Corp's Immix Biopharma position peaked at $391K in Q4 2025.
  • 109 funds tracked by Wall St. Rank held Immix Biopharma as of Q2 2026.

Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.